SNPX - Synaptogenix Inc
IEX Last Trade
4.05
0.520 12.840%
Share volume: 268,410
Last Updated: Fri 30 Aug 2024 08:57:22 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.53
0.52
14.73%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
8.98%
1 Month
-0.85%
3 Months
-10.90%
6 Months
-27.05%
1 Year
-69.45%
2 Year
-98.09%
Key data
Stock price
$4.05
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.27 - $13.25
52 WEEK CHANGE
-$0.69
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.
Recent news